Implantable Cardiac Rhythm Management Device Market Demand ,Status Analysis And Forecast Till 2026| Grand View Research, Inc
“The global implantable cardiac rhythm management device market size was estimated at USD 13.68 billion in 2018 and is anticipated to expand at a CAGR of 5.1% over the forecast period.�
The global implantable cardiac rhythm management device market size is expected to reach USD 20.39 billion by 2026 registering a CAGR of 5.1%, according to a new report by Grand View Research, Inc. Increasing geriatric population, cases of Cardiovascular Disease (CVDs), and demand for accurate and effective diagnostics of these diseases are the factors attributing to the growth of the market. Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorders in their lifetime. Hectic schedules and busy lifestyle are major factors that cause hypertension among individuals. An estimated 85.7 million Americans (i.e., almost 34% of the population) suffered from high Blood Pressure (BP) and hypertension due to stressful lifestyle. Almost 23.4 million American adults were diagnosed with diabetes in 2017, while an estimated additional 7.6 million American adults are undiagnosed diabetics. Thus, prevalence of CVDs is increasing in younger generation as well. Globally, the prevalence of diabetes is expected to increase to 7.7% by 2030. Various implantable devices, such as pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT), are being used for improved cardiac performance. Pacemakers are the mostly used devices for conduction disorders and sinus dysfunctions. CRT devices and ICDs are comparatively new and incorporate better technology than their older counterparts.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/implantable-cardiac-rhythmmanagement-device-market
Follow Us:
Further key findings from the study suggest:
Hospitals is expected to be the largest end use segment of the global implantable cardiac rhythm management (CRM) device market over the forecast period.
The CRT product segment is anticipated to witness the fastest growth due to implementation of supportive legislative policies in developed countries and increased awareness about these products
North America led the global market with a market share of more than 45% in 2018 due to higher awareness levels, supportive government policies, favorable reimbursement schemes, and increased cases of CVDs
Asia Pacific is expected to exhibit the fastest growth at a CAGR of 5.6% from 2019 to 2026 Key companies in the market include St. Jude Medical/Abbott Laboratories; Medtronic PLC; Boston Scientific; Biotronik; Physio-Control, Inc.; Schiller AG; Koninklijke Philips N.V.; Zoll Medical Corporation
Grand View Research has segmented the global implantable cardiac rhythm management device market on the basis of the product, end use, and region: Implantable CRM Devices Product Outlook (Revenue, USD Million, 2014 - 2026) Pacemaker
ICDs
CRT
Implantable CRM Devices End Use Outlook (Revenue, USD Million, 2014 - 2026) Hospital
Specialty Cardiac Center
Other
Implantable CRM Devices Regional Outlook (Revenue, USD Million, 2014 - 2026) North America
o
U.S.
o
Canada
Europe o
U.K.
o
Germany
Asia Pacific o
Japan
o
China
Latin America
Follow Us:

o
Brazil
o
Mexico
MEA o
South Africa
o
Saudi Arabia
Browse Related Category Reports @ www.grandviewresearch.com/industry/medical-devices Table of Content of Implantable Cardiac Rhythm Management Device Market Chapter 1 Methodology and Scope 1.1 Market Segmentation and Scope 1.1.1 Products 1.1.2 End Use 1.1.3 Region 1.1.4 Estimates and forecast timeline 1.2 Research Methodology 1.3 Information procurement 1.3.1 Purchased database: 1.3.2 GVR’s internal database 1.3.3 Secondary sources 1.3.4 Primary research 1.3.5 Details of primary research 1.3.5.1 Data for primary interviews in North america 1.3.5.2 Data for primary interviews in Europe 1.3.5.3 Data for primary interviews in Asia Pacific 1.3.5.4 Data for primary interviews in Middle East and Africa 1.4 Information or Data Analysis 1.4.1 Data analysis models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis 1.6.2 Volume price analysis (Model 2) 1.6.2.1 Approach 2: Volume price analysis
Follow Us:
1.7 List of Secondary Sources 1.8 List of Primary Sources 1.9 Objectives 1.9.1 Objective 1 1.9.2 Objective 2 1.9.3 Objective 3 1.9.4 Objective 4 Chapter 2 Executive Summary 2.1 Market Outlook 2.2 Segment Outlook Chapter 3 Implantable CRM Devices Market Variables, Trends & Scope 3.1 Market Dynamics 3.1.1 Market Driver Analysis 3.1.1.1 Increasing incidence of cardiac disorders 3.1.1.2 Favorable reimbursement policies 3.1.1.3 Growing geriatric population base 3.1.1.4 Growing adoption of sedentary lifestyle 3.1.2 Market Restrain Analysis 3.1.2.1 Stringent regulatory framework 3.2 CRM Devices: Market Analysis Tools 3.2.1 Industry Analysis - Porter’s 3.2.2 Pestle Analysis 3.2.3 Major Deals And Strategic Alliances 3.2.4 Cardiac Practices In U.S. 3.2.5 Number Of Cardiologist And Electrophysiologist In The U.S. 3.2.6 Implantable Loop Recorders (Ilr) Chapter 4 Implantable CRM Devices Market: Segment Analysis, by Product, 2014 - 2026 (USD Million) 4.1 Definition and Scope 4.2 Product Type Market Share Analysis, 2018 & 2026 4.3 Global Implantable CRM Devices Market, by Product, 2014 to 2026 4.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 4.4.1 Pacemaker
Follow Us:
4.4.1.1 Pacemaker, 2014 - 2026 (USD Million) 4.4.2 ICDs 4.4.2.1 ICDs, 2014 - 2026 (USD Million) 4.4.3 CRT 4.4.3.1 CRT, 2014 - 2026 (USD Million) Chapter 5 Implantable CRM Devices Market: Segment Analysis, By End Use, 2014 - 2026 (USD Million) 5.1 Definition and Scope 5.2 End-Use Type Market Share Analysis, 2018 & 2026 5.3 Global CRM devices Market, by End Use, 2014 to 2026 5.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 5.4.1 Hospitals 5.4.1.1 Hospitals Market, 2014 - 2026 (USD Million) 5.4.2 Specialty Cardiac Center 5.4.2.1 Specialty Cardiac Center, 2014 - 2026 (USD Million) 5.4.3 Others 5.4.3.1 Others, 2014 - 2026 (USD Million) Chapter 6 Implantable CRM Devices Market: Regional Market Analysis, by Product, End Use 2014 - 2026 (USD Million) 6.1 Definition & Scope 6.2 Regional Market Share Analysis, 2018 & 2026 6.3 Regional Market Snapshot 6.4 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2025 6.5 North America 6.5.1 North America Market Estimates And Forecast, By Country, 2014 - 2026 (USD Million) 6.5.2 North America Implantable Crm Devices Market, By Product, 2014 - 2026 (USD Million) 6.5.3 North America Implantable Crm Devices Market, By End Use, 2014 - 2026 (USD Million) 6.5.4 U.S. 6.5.4.1 U.S. implantable CRM devices market, 2014 - 2026 (USD Million) 6.5.5 Canada 6.5.5.1 Canada implantable CRM devices market, 2014 - 2026 (USD Million) 6.6 Europe 6.6.1 Europe Implantable Crm Devices Market, By Country, 2014 - 2026 (USD Million) 6.6.2 Europe Implantable Crm Devices Market, By Product, 2014 - 2026 (USD Million)
Follow Us:
6.6.3 Europe Implantable Crm Devices Market, By End Use, 2014 - 2026 (USD Million) 6.6.4 U.K. 6.6.4.1 U.K. implantable CRM devices market, 2014 - 2026 (USD Million) 6.6.5 Germany 6.6.5.1 Germany CRM devices market, 2014 - 2026 (USD Million) 6.7 Asia Pacific 6.7.1 Asia Pacific Implantable Crm Devices Market, By Country, 2014 - 2026 (USD Million) 6.7.2 Asia Pacific Implantable Crm Devices Market, By Product, 2014 - 2026 (USD Million) 6.7.3 Asia Pacific Implantable Crm Devices Market, By End Use, 2014 - 2026 (USD Million) 6.7.4 JAPAN 6.7.4.1 Japan implantation CRM devices market, 2014 - 2026 (USD Million) 6.7.5 CHINA (MAINLAND) 6.7.5.1 China (Mainland) CRM devices market, 2014 - 2026 (USD Million) 6.8 Latin America 6.8.1 Latin America Implantable Crm Devices Market, By Country, 2014 - 2026 (USD Million) 6.8.2 Latin America Implantable Crm Devices Market, By Product, 2014 - 2026 (USD Million) 6.8.3 Latin America Implantable Crm Devices Market, By End Use, 2014 - 2026 (USD Million) 6.8.4 Brazil 6.8.4.1 Brazil CRM devices market, 2014 - 2026 (USD Million) 6.8.5 Mexico 6.8.5.1 Mexico CRM devices market, 2014 - 2026 (USD Million) 6.9 MEA 6.9.1 MEA Implantable Crm Devices Market, By Country2014 - 2026 (USD MILLION) 6.9.2 Mea Implantable Crm Devices Market, By Product, 2014 - 2026 (USD Million) 6.9.3 Mea Implantable Crm Devices Market, By End Use, 2014 - 2026 (USD Million) 6.9.4 South Africa 6.9.4.1 South Africa implantable CRM devices market, 2014 - 2026 (USD Million) 6.9.5 SAUDI ARABIA 6.9.5.1 Saudi Arabia implantable CRM devices market, 2014 - 2026 (USD Million) Chapter 7 Implantable CRM Devices Market - Competitive Analysis 7.1 Company Profiles 7.2 Physio-Control Inc
Follow Us:
7.2.1 Company Overview 7.2.2 Financial Performance 7.2.3 Product Benchmarking 7.2.4 Strategic Initiatives 7.3 Schiller 7.3.1 Company Overview 7.3.2 Product Benchmarking 7.3.3 Strategic Initiatives 7.4 Medtronic 7.4.1 Company Overview 7.4.2 Financial Performance 7.4.3 Product Benchmarking 7.4.4 Strategic Initiatives 7.5 St Jude Medical 7.5.1 Company Overview 7.5.2 Financial Performance 7.5.3 Product Benchmarking 7.5.4 Strategic Initiatives 7.6 Boston Scientific 7.6.1 Company Overview 7.6.2 Financial Performance 7.6.3 Product Benchmarking 7.6.4 Strategic Initiatives 7.7 Koninklijke Philips N.V. 7.7.1 Company Overview 7.7.2 Financial Performance 7.7.3 Product Benchmarking 7.7.4 Strategic Initiatives 7.8 Zoll Medical Corporation 7.8.1 Company Overview 7.8.2 Product Benchmarking 7.8.3 Strategic Initiatives
Follow Us:
7.9 Biotronik 7.9.1 Company Overview 7.9.2 Product Benchmarking 7.9.3 Strategic Initiatives
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us:
Follow Us: